Growth Metrics

BioNTech SE (BNTX) Cash from Investing Activities (2018 - 2025)

BioNTech SE's Cash from Investing Activities history spans 8 years, with the latest figure at -$3.2 billion for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities fell 589.38% to -$3.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.9 billion, a 29.47% decrease, with the full-year FY2025 number at -$2.8 billion, down 25.4% from a year prior.
  • Cash from Investing Activities hit -$3.2 billion in Q4 2025 for BioNTech SE, down from $648.3 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for BNTX hit a ceiling of $648.3 million in Q4 2024 and a floor of -$3.2 billion in Q4 2025.
  • Historically, Cash from Investing Activities has averaged -$898.1 million across 5 years, with a median of -$208.0 million in 2024.
  • Biggest five-year swings in Cash from Investing Activities: surged 96043426.27% in 2021 and later crashed 1865.35% in 2023.
  • Tracing BNTX's Cash from Investing Activities over 5 years: stood at $114.3 million in 2021, then soared by 43.73% to $164.3 million in 2022, then crashed by 1865.35% to -$2.9 billion in 2023, then surged by 122.36% to $648.3 million in 2024, then crashed by 589.38% to -$3.2 billion in 2025.
  • Business Quant data shows Cash from Investing Activities for BNTX at -$3.2 billion in Q4 2025, $648.3 million in Q4 2024, and -$156.1 million in Q3 2024.